TrialBlood2012

RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia.

Josephine Aimiuwu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.